Neuromyelitis Optica Spectrum Disease (NMOSD)
4 clinical trials · Condition
◉ Watch Neuromyelitis Optica Spectrum Disease (NMOSD)
| Record | Firm | Date |
|---|---|---|
| Riptylimab for the Treatment of Optic Neuritis and Myelitis Spectrum Diseases (NCT07685678) | Zhongming Qiu | 2026-07-15 |
| The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder. (NCT07592754) | Chinese PLA General Hospital | 2026-05-15 |
| A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases (NCT06869278) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2025-06-17 |
| Meningococcal Vaccination in Patients on Complement Inhibitors (NCT06906692) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2025-03-25 |
Track Neuromyelitis Optica Spectrum Disease (NMOSD) automatically
Every clearance here is in the API, with alerts when new ones post.